BARBUI, Corrado
 Distribuzione geografica
Continente #
NA - Nord America 26.291
EU - Europa 24.340
AS - Asia 18.073
SA - Sud America 2.805
AF - Africa 624
OC - Oceania 110
Continente sconosciuto - Info sul continente non disponibili 17
Totale 72.260
Nazione #
US - Stati Uniti d'America 25.707
RU - Federazione Russa 8.307
SG - Singapore 7.985
GB - Regno Unito 6.262
CN - Cina 4.512
IT - Italia 2.756
BR - Brasile 2.237
HK - Hong Kong 1.710
VN - Vietnam 1.639
FR - Francia 1.465
DE - Germania 1.443
IE - Irlanda 1.104
FI - Finlandia 956
SE - Svezia 905
KR - Corea 611
CA - Canada 387
UA - Ucraina 374
IN - India 239
TR - Turchia 205
ID - Indonesia 204
AR - Argentina 195
NL - Olanda 164
BD - Bangladesh 158
NG - Nigeria 151
JP - Giappone 129
MX - Messico 108
ZA - Sudafrica 108
ES - Italia 107
AT - Austria 104
IQ - Iraq 102
AU - Australia 91
EC - Ecuador 90
PL - Polonia 80
PK - Pakistan 73
BE - Belgio 69
BJ - Benin 58
VE - Venezuela 58
CO - Colombia 56
TG - Togo 55
UZ - Uzbekistan 52
MA - Marocco 51
PH - Filippine 49
PE - Perù 48
SA - Arabia Saudita 48
MY - Malesia 42
CL - Cile 41
KE - Kenya 41
IL - Israele 35
PY - Paraguay 34
UY - Uruguay 31
JO - Giordania 30
EG - Egitto 29
TN - Tunisia 28
AZ - Azerbaigian 26
IR - Iran 24
RO - Romania 23
AE - Emirati Arabi Uniti 22
LT - Lituania 21
OM - Oman 19
TH - Thailandia 19
TW - Taiwan 19
CZ - Repubblica Ceca 18
HU - Ungheria 18
BG - Bulgaria 17
ET - Etiopia 16
GR - Grecia 16
CH - Svizzera 15
NZ - Nuova Zelanda 15
DZ - Algeria 14
EU - Europa 14
NO - Norvegia 14
NP - Nepal 14
SN - Senegal 14
BY - Bielorussia 13
JM - Giamaica 13
KZ - Kazakistan 13
PT - Portogallo 13
BO - Bolivia 12
DO - Repubblica Dominicana 12
PS - Palestinian Territory 12
CR - Costa Rica 10
LB - Libano 10
PA - Panama 10
HN - Honduras 9
RS - Serbia 9
SK - Slovacchia (Repubblica Slovacca) 9
AL - Albania 8
DK - Danimarca 8
KG - Kirghizistan 8
SI - Slovenia 8
CG - Congo 7
LK - Sri Lanka 7
BB - Barbados 6
GE - Georgia 6
GT - Guatemala 6
HR - Croazia 6
AM - Armenia 5
AO - Angola 5
BH - Bahrain 5
EE - Estonia 5
Totale 72.116
Città #
Southend 5.506
Singapore 4.252
Ashburn 2.789
Jacksonville 2.745
Moscow 2.492
San Jose 2.342
Dallas 2.308
Chandler 2.239
Woodbridge 1.651
Hong Kong 1.614
Houston 1.181
Verona 1.135
Dublin 1.068
Ann Arbor 1.065
The Dalles 909
Beijing 727
Wilmington 529
Ho Chi Minh City 509
Lawrence 504
Princeton 501
New York 443
Los Angeles 371
Hanoi 317
Nanjing 308
Jinan 297
Buffalo 285
Munich 280
Shenyang 240
Milan 234
Sindelfingen 212
Helsinki 203
Redondo Beach 200
São Paulo 195
Hebei 176
Santa Clara 160
Tianjin 157
Council Bluffs 155
Abuja 145
London 142
Montréal 137
Columbus 133
Mcallen 131
Dong Ket 130
Boardman 128
Jakarta 118
Changsha 114
Nanchang 113
Tokyo 110
Haikou 109
Lappeenranta 102
Rome 102
Frankfurt am Main 100
Ningbo 96
Guangzhou 94
Orem 91
Dearborn 90
Hangzhou 89
Toronto 89
Chicago 85
Seattle 83
Washington 83
Zhengzhou 83
Amsterdam 80
Jiaxing 75
San Francisco 75
Montreal 72
Norwalk 72
Nuremberg 71
Rio de Janeiro 71
Redwood City 68
Taizhou 66
Johannesburg 64
Da Nang 63
Haiphong 60
Taiyuan 60
Warsaw 59
Cotonou 58
Belo Horizonte 56
Lomé 55
Vienna 55
Brussels 54
Lanzhou 53
Turku 52
Chennai 51
Brooklyn 49
Bologna 48
Manchester 47
Istanbul 46
Atlanta 45
Boston 43
Mexico City 43
Fairfield 42
Kent 42
Stockholm 42
Tashkent 42
Baghdad 41
Curitiba 41
Redmond 40
Brasília 39
Denver 36
Totale 45.072
Nome #
Forty years without mental hospitals in Italy 667
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 576
WHO Mental Health Gap Action Programme (mhGAP) Intervention Guide: a systematic review of evidence from low and middle-income countries 500
Beyond pain: can antidepressants improve depressive symptoms and quality of life in patients with neuropathic pain? A systematic review and meta-analysis 475
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 405
A Methodology for Adapting the WHO Evidence-Based Self-Help+ Intervention for Stress Management via Chatbot 309
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 304
Come reagiscono al trauma i bambini sfollati? Un’analisi esplorativa degli studi condotti in contesti di guerra. [Displaced versus non-displaced children in war contexts: An explorative analysis of psychological reactions to war experiences] 264
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 243
Cerebral atrophy and white matter disruption in chronic schizophrenia 239
Il trattamento farmacologico degli attacchi di panico in medicina generale 233
Assessment of cerebral blood volume in schizophrenia: a magnetic resonance imaging study 232
Access to and use of psychiatric services by migrants resettled in Northern Italy 231
Psychological and psychosomatic symptoms of second victims of adverse events: a systematic review and meta-analysis 230
A network meta-analysis of psychosocial interventions for refugees and asylum seekers with PTSD 229
Psychological treatments versus treatment as usual for obsessive compulsive disorder 228
Adverse effects of antipsychotic drugs: survey of doctors' versus patients' perspective. 225
Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications 220
Psychosocial interventions for post-traumatic stress disorder in refugees and asylum seekers resettled in high-income countries: Systematic review and meta-analysis 220
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 219
Common mental disorders in asylum seekers and refugees: umbrella review of prevalence and intervention studies 219
A Chat-Bot Based Version of the WHO-validated Intervention Self-Help+ for Stress Management in Breast Cancer Patients: Protocol for a Pilot Feasibility Study 217
Dealing with adverse events: a meta-analysis on second victims' coping strategies 214
Antidepressants and benzodiazepines for panic disorder in adults 212
A practical framework for academics to implement public engagement interventions and measure their impact 211
Cortical white-matter microstructure in schizophrenia. Diffusion imaging study. 211
Academic psychiatry and the pharmaceutical industry: useful partnership or dangerous interaction? 205
Efficacia della “Terapia per l’adesione al trattamento” sulla qualità della vita di persone affette da schizofrenia e dei loro familiari (progetto QUATRO). Razionale dello studio e metodologia 205
Access to mental health services and psychotropic drug use in refugees and asylum seekers hosted in high-income countries 204
Clinical interventions for treatment non-adherence in psychosis: meta-analysis 204
Antipsychotic Dose Mediates the Association between Polypharmacy and Corrected QT Interval 198
A simple approach to manage dosages in drug-epidemiology research 195
Assessing risk of bias in randomized controlled trials 194
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 194
Avoidable mortality of psychiatric patients in an area with a community-based system of mental health care. 194
A New Approach to Psychiatric Drug Approval in Europe 193
Making the use of psychotropic drugs more rational through the development of GRADE recommendations in specialist mental healthcare 190
Ricostruzione tridimensionale della volumetria cerebrale nella schizofrenia 189
Antipsychotic drug exposure and risk of myocardial infarction 186
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 185
Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature 185
Continuing, reducing, switching, or stopping antipsychotics in individuals with schizophrenia-spectrum disorders who are clinically stable: a systematic review and network meta-analysis 184
Allocation concealment and blinding in clinical trials 184
Drug dose as mediator of treatment effect in antidepressant drug trials: the case of fluoxetine 184
Factors associated with first- versus second-generation long-acting antipsychotics prescribed under ordinary clinical practice in Italy 184
Predicting costs of mental health care: a critical literature review 183
"Wish bias" in antidepressant drug trials? 183
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 182
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 181
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 181
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 180
Efficacy and acceptability of antidepressants in patients with ischemic heart disease: systematic review and meta-analysis 180
Does formulation matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies 179
Maintenance treatment with long-acting injectable antipsychotics for people with nonaffective psychoses: a network meta-analysis 179
Antidepressive Monotherapie 178
What is the WHO essential medicines list? 178
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 177
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 176
Azapirones versus placebo for panic disorder in adults 176
Guideline implementation strategies for specialist mental healthcare. 175
Association of traumatic events with levels of psychological distress and depressive symptoms in male asylum seekers and refugees resettled in Italy 175
Efficacy and acceptability of psychosocial interventions in asylum seekers and refugees: systematic review and meta-analysis 174
Efficacy of physical activity interventions on psychological outcomes in refugee, asylum seeker and migrant populations: a systematic review and meta-analysis 173
Rigour of development of clinical practice guidelines for the pharmacological treatment of bipolar disorder: systematic review 172
A systematic review of cognitive effects of exercise in depression 172
Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries 171
Sertraline versus other antidepressive agents for depression 171
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 170
Agomelatine and the brave old world of narrative-based medicine 170
Antidepressants for the treatment of depression in people with cancer 170
Are trials of psychological and psychosocial interventions for schizophrenia and psychosis included in the NICE guidelines pragmatic? A systematic review 170
A cross-sectional audit of benzodiazepine use among general practice patients. 170
Amitriptyline versus other types of pharmacotherapy for depression 169
Effectiveness and cost-effectiveness of Self-Help Plus (SH+) for preventing mental disorders in refugees and asylum seekers in Europe and Turkey: study protocols for two randomised controlled trials 169
Are all antidepressants really the same? The case of fluoxetine: a systematic review 168
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials 168
Response rates in patients with schizophrenia and positive symptoms receiving cognitive behavioural therapy: a systematic review and single-group meta-analysis 168
Effectiveness of a Self-Guided Digital Intervention for Mental Health and Psychological Well-Being in University Students: Pre- and Postintervention Study 166
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 166
Efficacia della “Terapia per l’adesione al trattamento” sulla qualità della vita di persone affette da schizofrenia e dei loro familiari (progetto QUATRO). Modalità di arruolamento dei soggetti nel centro di Verona e tipo di intervento 166
First-generation antipsychotics and QTc: any role for mediating variables? 166
Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence 165
Imputing missing standard deviations in meta-analyses can provide accurate results 164
Benzodiazepines and risk of dementia: true association or reverse causation? 163
Amitriptyline versus other tricyclic drugs and selectivev serotonine reuptake inhibitors (SSRIs) for depression [Protocoll] 161
Commentary: Antipsychotic plus mood stabiliser co-therapy is more effective than mood stabiliser mono-therapy at reducing acute bipolar mania 161
Implementation of treatment guidelines for specialist mental health care 161
Off-label and non-classical prescriptions of antipsychotic agents in ordinary inpatient practice 158
Antipsychotic drug exposure and risk of fracture: a systematic review and meta-analysis of observational studies 158
Behavioural activation therapy for depression in adults with non-communicable diseases 158
Effectiveness of Self-Help Plus in preventing mental disorders in refugees and asylum seekers in Western Europe: a multinational randomized controlled trial 158
Antidepressant and antipsychotic drug prescribing in general population in Lombardy (in Italian) 157
Citalopram versus other anti-depressive agents for depression. 157
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 157
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial 157
Comparing long-acting antipsychotic discontinuation rates under ordinary clinical circumstances: a survival analysis from an observational, pragmatic study 157
Profilo di efficacia e tollerabilità dell'escitalopram rispetto agli altri farmaci antidepressivi nel trattamento acuto della depressione maggiore: revisione sistematice e meta-analisi. [Efficacy and tolerability profile of escitalopram versus other antidepressants in the acute treatment of major depressive disorder: A systematic review and meta-analysis] 156
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 156
Is the efficacy of antidepressants in panic disorder mediated by adverse events? A mediational analysis 156
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 155
Totale 20.457
Categoria #
all - tutte 238.718
article - articoli 230.098
book - libri 1.219
conference - conferenze 1.465
curatela - curatele 0
other - altro 2.228
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.708
Totale 477.436


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021826 0 0 0 0 0 0 0 0 0 146 410 270
2021/20223.270 184 725 57 154 249 64 39 221 134 106 340 997
2022/20237.161 602 496 801 1.178 690 1.566 102 479 849 88 189 121
2023/20244.040 209 367 319 448 529 576 205 260 61 180 502 384
2024/202511.203 704 714 557 1.746 589 416 636 585 1.709 831 733 1.983
2025/202629.209 2.289 1.710 2.567 4.447 7.133 2.174 3.055 1.920 2.457 1.457 0 0
Totale 72.790